Why men may not get genetic testing for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at why some men with metastatic prostate cancer do or don't get a genetic test called NGS. It aims to find barriers to testing, so doctors can better help patients in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man with metastatic prostate cancer (cancer that has spread to other parts of the body).
- You are a new patient at Johns Hopkins Medical Oncology between January 1, 2025 and December 31, 2026.
- You have not had next-generation sequencing (NGS) genetic testing for your cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers support from a trained peer to help African American men understand and go through genetic testing for prostate cancer. It may help you feel less overwhelmed and better prepared during the testing and decision-making process.
This study helps prostate cancer survivors get genetic testing for inherited cancer risk. It aims to make testing easier to access and understand.
This study tests a program that trains men (especially African American men) to help others understand prostate cancer genetic counseling and testing. It may improve access to this information by using peer support and patient navigation.
This study tests a new tool to help Black or African American men with prostate cancer understand genetic testing options. The goal is to improve counseling and decision-making about tumor genetic testing.
This study looks at how patients and doctors feel about genetic testing for prostate cancer. It aims to improve how genetic risk information is shared and understood.
This study tests a community health coach to help Black men with prostate cancer understand and access genetic testing that looks for inherited cancer risk. It may help you talk with your care team about testing and reduce barriers to getting results.
Hear when a new Metastatic Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.